Stockscreener 앱 받기
239.72
0.02%
0.04
시간 외 거래:
239.72
전일 마감가:
$239.68
열려 있는:
$236.69
하루 거래량:
676.61K
Relative Volume:
1.23
시가총액:
$20.06B
수익:
$12.71B
순이익/손실:
$435.50M
주가수익비율:
46.55
EPS:
5.15
순현금흐름:
$843.20M
1주 성능:
+1.22%
1개월 성능:
-3.27%
6개월 성능:
+6.74%
1년 성능:
+13.63%
1일 변동 폭
$232.11
$240.75
1주일 범위
$232.11
$242.65
52주 변동 폭
$191.97
$258.59
래버러토리 코퍼레이션 Stock (LH) Company Profile
명칭
Labcorp Holdings Inc
전화
(336) 229-1127
주소
358 S MAIN ST, BURLINGTON, NC
LH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
239.72 | 20.06B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
518.41 | 195.58B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.26 | 150.27B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
122.21 | 34.86B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
422.15 | 34.33B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
186.94 | 32.96B | 15.41B | 1.37B | 2.11B | 7.50 |
래버러토리 코퍼레이션 Stock (LH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-30 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-10-01 | 개시 | Piper Sandler | Neutral |
| 2024-03-25 | 업그레이드 | Argus | Hold → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-09 | 개시 | Evercore ISI | In-line |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-19 | 다운그레이드 | Argus | Buy → Hold |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-11 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 재개 | Deutsche Bank | Buy |
| 2020-05-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-04-29 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2019-07-16 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Buy |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-10-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 재개 | BofA/Merrill | Buy |
| 2018-06-07 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 개시 | Argus | Buy |
모두보기
래버러토리 코퍼레이션 주식(LH)의 최신 뉴스
Why Labcorp (LH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - Simply Wall St
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Truist maintains Buy on LabCorp stock, keeps $285 target By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com Australia
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 - Investing.com
Should Labcorp Stock Stay In Your Portfolio Right Now? - Barchart
Should Labcorp Stock Stay in Your Portfolio Right Now? - Yahoo Finance
Labcorp Faces Mixed Investor Reactions Amid Market FluctuationsNews and Statistics - IndexBox, Inc.
Citigroup Upgrades Labcorp Holdings (LH) - MSN
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock By Investing.com - Investing.com South Africa
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock - Investing.com India
Labcorp Holdings Insider Sold Shares Worth $1,330,639, According to a Recent SEC Filing - Marketscreener.com
What 10 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Citigroup Upgrades Labcorp Holdings to Buy From Neutral, Adjusts Price Target to $300 From $250 - Marketscreener.com
Fortrea Faces Spin-Related Challenges in the Near Term; Positive Long-Term Outlook - Morningstar
Is the Market Bullish or Bearish on Labcorp Hldgs? - Benzinga
Labcorp Expects Major Revenue Growth Thanks To Rising Test Demand - Finimize
Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labco - GuruFocus.com
Labcorp Executive Cashes In on Stock Sale! - TipRanks
Labcorp Holdings EVP sells $330,208 in stock By Investing.com - Investing.com Australia
Labcorp Holdings EVP sells $330,208 in stock - Investing.com India
LabCorp Holdings EVP Sells Shares - TradingView
Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus.com
LabCorp EVP Amy Summy sells $56,590 in common stock By Investing.com - Investing.com South Africa
Are Wall Street Analysts Predicting Labcorp Holdings Stock Will Climb or Sink? - MSN
LabCorp EVP Amy Summy sells $56,590 in common stock - Investing.com India
Here's Why Labcorp (LH) is a Strong Value Stock - Nasdaq
Ex-Dividend Reminder: Molson Coors Beverage, Marriott International and Labcorp Holdings - Nasdaq
래버러토리 코퍼레이션 (LH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.57%
3.14%
자본화:
|
볼륨(24시간):